Seroatlas · Human Serome Atlas

OLFM4

Olfactomedin-4

Also known as: GC1, GW112, OlfD, OLFM4_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q6UX06
Gene
OLFM4
Ensembl
ENSG00000102837
Chromosome
13
Canonical length
510 aa
Protein class
Predicted secreted proteins
Subcellular location
Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol
Secretome location
Secreted to digestive system
Quaternary structure
Homomultimer

OverviewNCBI Gene

This gene was originally cloned from human myeloblasts and found to be selectively expressed in inflammed colonic epithelium. This gene encodes a member of the olfactomedin family. The encoded protein is an antiapoptotic factor that promotes tumor growth and is an extracellular matrix glycoprotein that facilitates cell adhesion. [provided by RefSeq, Mar 2011]

Canonical amino-acid sequenceUniProt

510 residues, UniProt reviewed canonical sequence.

>Q6UX06|OLFM4
     1  MRPGLSFLLA LLFFLGQAAG DLGDVGPPIP SPGFSSFPGV DSSSSFSSSS RSGSSSSRSL
    61  GSGGSVSQLF SNFTGSVDDR GTCQCSVSLP DTTFPVDRVE RLEFTAHVLS QKFEKELSKV
   121  REYVQLISVY EKKLLNLTVR IDIMEKDTIS YTELDFELIK VEVKEMEKLV IQLKESFGGS
   181  SEIVDQLEVE IRNMTLLVEK LETLDKNNVL AIRREIVALK TKLKECEASK DQNTPVVHPP
   241  PTPGSCGHGG VVNISKPSVV QLNWRGFSYL YGAWGRDYSP QHPNKGLYWV APLNTDGRLL
   301  EYYRLYNTLD DLLLYINARE LRITYGQGSG TAVYNNNMYV NMYNTGNIAR VNLTTNTIAV
   361  TQTLPNAAYN NRFSYANVAW QDIDFAVDEN GLWVIYSTEA STGNMVISKL NDTTLQVLNT
   421  WYTKQYKPSA SNAFMVCGVL YATRTMNTRT EEIFYYYDTN TGKEGKLDIV MHKMQEKVQS
   481  INYNPFDQKL YVYNDGYLLN YDLSVLQKPQ

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against OLFM4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.36
Highest tissue expression
1,220 nTPM

Expression across tissuesHPA

Tissue

  • small intestine: 1,220 nTPM
  • duodenum: 1,141 nTPM
  • pancreas: 666 nTPM
  • rectum: 533 nTPM
  • colon: 423 nTPM
  • vagina: 265 nTPM

Single-cell type

  • paneth cells: 6,606 nCPM
  • prostatic club cells: 5,606 nCPM
  • enteric stem cells: 3,771 nCPM
  • neutrophil progenitors: 3,094 nCPM
  • gastric progenitor cells: 1,997 nCPM
  • enteric transient amplifying cells: 1,900 nCPM

Immune cell

  • neutrophil: 0.1 nTPM
  • total PBMC: 0.1 nTPM
  • basophil: 0 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM
  • gdT-cell: 0 nTPM

Brain region

  • basal ganglia: 0.9 nTPM
  • cerebral cortex: 0.9 nTPM
  • hypothalamus: 0.7 nTPM
  • amygdala: 0.4 nTPM
  • midbrain: 0.4 nTPM
  • spinal cord: 0.4 nTPM

ReferencesPubMed · IEDB

Publications for OLFM4 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.1
gnomAD pLI
0
gnomAD missense Z
0.34
DepMap mean gene effect
0.02
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of OLFM4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads OLFM4 as an antibody target. Whether an autoantibody or antibody against OLFM4 could matter depends on whether native OLFM4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

OLFM4 is annotated at the cell surface, where native OLFM4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label OLFM4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/OLFM4. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...